Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on ASTELLAS PHARMA INC
6d ago ASTELLAS PHARMA : -Launch of Suglat Tablets, a Selective SGLT2 Inhibitor for Tre..
6d ago ASTELLAS PHARMA : US, Inc. to Pay $7.3 Million to Resolve False Claims Act Alleg..
7d ago ASTELLAS PHARMA : Launch of Suglat® Tablets, a Selective SGLT2 Inhibitor for Tre..
7d ago ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Yields New Data on HIV/AID..
7d ago ASTELLAS PHARMA : US Inc. to Pay $7.3 Million to Resolve False Claims Act Allega..
7d ago ASTELLAS PHARMA : Illinois-based Astellas to pay $7.3M settlement
7d ago ASTELLAS PHARMA : to pay $7.3M in drug-marketing settlement
04/15 ASTELLAS PHARMA : Named National Presenting Sponsor of the National Kidney Found..
04/09 Seattle Genetics Showcases Antibody-Drug Conjugate (ADC) Program and Technolo..
04/08 Seattle Genetics Highlights Antibody-Drug Conjugate (ADC) Program and Technol..
04/04 ASTELLAS PHARMA : Announces marketing authorisation application for xtandi (enza..
04/03 ASTELLAS PHARMA : ANNOUNCES MARKETING AUTHORISATION APPLICATION FOR XTANDI&trade..
03/31 ASTELLAS PHARMA : Establishment of Regenerative Medicine Unit
03/31 ASTELLAS PHARMA : NCCN Receives $2.2 Million in Research Funding from Astellas a..
03/27 ASTELLAS PHARMA INC : ex-dividend day for final dividend
03/27 ASTELLAS PHARMA INC : SPLIT: 5 of 1
03/26 ASTELLAS PHARMA : and Daiichi Sankyo Form Compound Library Sharing Partnership
03/25 ASTELLAS PHARMA : Announces Marketing Approval in Japan for XTANDI (enzalutamide..
03/24 ASTELLAS PHARMA : Announces Marketing Approval in Japan for XTANDI® (enzalutamid..
03/23 ASTELLAS PHARMA : and Medivation Submit sNDA for XTANDI (Enzalutamide) for Chemo..
03/21 ASTELLAS PHARMA : HHS Assigned Patent
03/20 ASTELLAS PHARMA : Pediatric Praziquantel Consortium awarded US$1.86 million GHIT..
03/19 ASTELLAS PHARMA : American Urological Association And Astellas Team Up To Secure..
03/18 ASTELLAS PHARMA : And medivation submit supplemental new drug application for xt..
03/18 ASTELLAS PHARMA : and Medivation Submit Supplemental New Drug Application for XT..
03/17 ASTELLAS PHARMA : Awarded Diversity Management Selection 100
03/16 ASTELLAS PHARMA : Awarded Diversity Management Selection 100 (pdf 196KB)
03/14 ASTELLAS PHARMA : American Urological Association and Astellas Team up to Secure..
03/05 ASTELLAS PHARMA INC : Astellas Secures Exclusive Rights to Commercialize Isavuco..
03/03 ASTELLAS PHARMA INC : Astellas Secures Exclusive Rights to Commercialize Isavuco..
03/03 ASTELLAS PHARMA INC : Basilea swaps its isavuconazole North American co-promote ..
02/28 ASTELLAS PHARMA INC : Astellas Secures Exclusive Rights to Commercialize Isavuco..
02/28 ASTELLAS PHARMA INC : Astellas Announces Stock Split and Partial Amendment to th..
02/28 ASTELLAS PHARMA INC : AVEO and Astellas to Halt Collaboration & License Deal for..
02/28 ASTELLAS PHARMA INC : AVEO and Astellas Report Plans to End Worldwide Collaborat..
02/26 ASTELLAS PHARMA INC : Studies from Astellas Pharma, Inc. Yield New Information a..
02/26 ASTELLAS PHARMA INC : Agensys Assigned Patent
02/24 ASTELLAS PHARMA INC : OSI Pharmaceuticals Assigned Patent
02/20 ASTELLAS PHARMA INC : AVEO and Astellas Report Plans to End Worldwide Collaborat..
02/19 ASTELLAS PHARMA INC : Studies from Astellas Pharma, Inc. Have Provided New Data ..
02/19 ASTELLAS PHARMA INC : AVEO and Astellas to Halt Collaboration & License Deal for..
02/17 AVEO PHARMACEUTICALS, INC. : AVEO and Astellas to End Worldwide Collaboration & ..
02/12 ASTELLAS PHARMA INC : Findings from Astellas Pharma, Inc. Update Knowledge of Cl..
02/12 ASTELLAS PHARMA INC : Recent Research from Astellas Pharma, Inc. Highlight Findi..
02/09 AVEO GROUP : Aveo and Astellas to Discontinue Phase 2 Trial of Tivozanib in Brea..
02/05 ASTELLAS PHARMA INC : Reorganization of Astellas' Global Management Structure (p..
02/04 AVEO GROUP : Aveo and Astellas to Discontinue Phase 2 Trial of Tivozanib in Brea..
01/17 ASTELLAS PHARMA INC : Approval of Suglat® Tablets, a Selective SGLT2 Inhibitor f..
01/15 ASTELLAS PHARMA INC : Astellas Pharma: Launches Irribow OD Tablets in Japan for ..
01/15 ASTELLAS PHARMA INC : Astellas and UMN Announce Summary Results in Phase III Cli..
01/14 ASTELLAS PHARMA INC : Astellas Pharma: Launches Irribow® OD Tablets in Japan for..
01/08 ASTELLAS PHARMA INC : Study Findings from Astellas Pharma, Inc. Broaden Understa..
01/07 ASTELLAS PHARMA INC : ASTELLAS TO FORM STRATEGIC PARTNERSHIP WITH CLEARPATH TO B..
01/06 ASTELLAS PHARMA INC : ASTELLAS TO FORM STRATEGIC PARTNERSHIP WITH CLEARPATH TO B..
01/02 ASTELLAS PHARMA INC : Researchers from Astellas Pharma, Inc. Provide Details of ..
2013 ASTELLAS PHARMA INC : Astellas and IBL Concludes Co-Research Agreement Regarding..
2013 ASTELLAS PHARMA INC : Study Data from Astellas Pharma, Inc. Update Knowledge of ..
2013 ASTELLAS PHARMA INC : Approval of Additional Indication for Hypnosedative, Dormi..
2013 ASTELLAS PHARMA INC : ASTELLAS -Notice of Completion of Acquisition of Own Share..
2013 ASTELLAS PHARMA INC : Production Subsidiary Astellas Pharma Tech Concludes Defin..
2013 ASTELLAS PHARMA INC : Notice of Completion of Acquisition of Own Shares
2013 ASTELLAS PHARMA INC : FDA Grants Astellas Qualified Infectious Disease Product D..
2013 VICAL INCORPORATED : Astellas, Vical Initiate Phase 2 Trial of ASP0113 Vaccine i..
2013 ASTELLAS PHARMA INC : Japanese Astellas Pharma to open office in Serbia on Dec 1..
2013 ASTELLAS PHARMA INC : Astellas Concludes Agreement with Mitsui Fudosan Comprehen..
2013 ASTELLAS PHARMA INC : Research Data from Astellas Pharma, Inc. Update Understand..
2013 ASTELLAS PHARMA INC : OSI Pharmaceuticals Assigned Patent
2013 OSI Pharmaceuticals Assigned Patent
2013 ASTELLAS PHARMA INC : Astellas named 'Company of the Year' at international SCRI..
2013 Astellas named 'Company of the Year' at international SCRIP Awards 2013
2013 New Therapeutics Study Results Reported from Astellas Pharma, Inc.
2013 ASTELLAS PHARMA INC : New Therapeutics Study Results Reported from Astellas Phar..
2013 Nobel Laureate, Dr. Elizabeth H.Blackburn Joins Panel of The Astellas Innovat..
2013 ASTELLAS PHARMA INC : Nobel Laureate, Dr. Elizabeth H.Blackburn Joins Panel of T..
2013 ASTELLAS PHARMA INC : ASTELLAS -Support to Philippines Typhoon Haiyan and the Bo..
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
Astellas Pharma Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF